Ładuje się......

A potent HNF4α agonist reveals that HNF4α controls genes important in inflammatory bowel disease and Paneth cells.

HNF4α has been implicated in IBD through a number of genome-wide association studies. Recently, we developed potent HNF4α agonists, including N-trans caffeoyltyramine (NCT). NCT was identified by structural similarity to previously the previously identified but weak HNF4α agonists alverine and benfl...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Seung-Hee Lee, Vimal Veeriah, Fred Levine
Format: Artigo
Język:Inglês
Wydane: Public Library of Science (PLoS) 2022-01-01
Seria:PLoS ONE
Dostęp online:https://doi.org/10.1371/journal.pone.0266066
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!